Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP

Cellular entry of the hepatitis B and D viruses (HBV/HDV) requires binding of the viral surface polypeptide preS1 to the hepatobiliary transporter Na+-taurocholate co-transporting polypeptide (NTCP). This interaction can be blocked by bulevirtide (BLV, formerly Myrcludex B), a preS1 derivative and a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Liu, Hongtao (VerfasserIn) , Zakrzewicz, Dariusz (VerfasserIn) , Nosol, Kamil (VerfasserIn) , Irobalieva, Rossitza N. (VerfasserIn) , Mukherjee, Somnath (VerfasserIn) , Bang-Sørensen, Rose (VerfasserIn) , Goldmann, Nora (VerfasserIn) , Kunz, Sebastian (VerfasserIn) , Rossi, Lorenzo (VerfasserIn) , Kossiakoff, Anthony A. (VerfasserIn) , Urban, Stephan (VerfasserIn) , Glebe, Dieter (VerfasserIn) , Geyer, Joachim (VerfasserIn) , Locher, Kaspar (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 March 2024
In: Nature Communications
Year: 2024, Jahrgang: 15, Pages: 1-13
ISSN:2041-1723
DOI:10.1038/s41467-024-46706-w
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41467-024-46706-w
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41467-024-46706-w
Volltext
Verfasserangaben:Hongtao Liu, Dariusz Zakrzewicz, Kamil Nosol, Rossitza N. Irobalieva, Somnath Mukherjee, Rose Bang-Sørensen, Nora Goldmann, Sebastian Kunz, Lorenzo Rossi, Anthony A. Kossiakoff, Stephan Urban, Dieter Glebe, Joachim Geyer, Kaspar P. Locher

MARC

LEADER 00000caa a2200000 c 4500
001 1894695844
003 DE-627
005 20250118001249.0
007 cr uuu---uuuuu
008 240709s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41467-024-46706-w  |2 doi 
035 |a (DE-627)1894695844 
035 |a (DE-599)KXP1894695844 
035 |a (OCoLC)1475301841 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Liu, Hongtao  |e VerfasserIn  |0 (DE-588)1335046445  |0 (DE-627)1894695712  |4 aut 
245 1 0 |a Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP  |c Hongtao Liu, Dariusz Zakrzewicz, Kamil Nosol, Rossitza N. Irobalieva, Somnath Mukherjee, Rose Bang-Sørensen, Nora Goldmann, Sebastian Kunz, Lorenzo Rossi, Anthony A. Kossiakoff, Stephan Urban, Dieter Glebe, Joachim Geyer, Kaspar P. Locher 
264 1 |c 20 March 2024 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.07.2024 
520 |a Cellular entry of the hepatitis B and D viruses (HBV/HDV) requires binding of the viral surface polypeptide preS1 to the hepatobiliary transporter Na+-taurocholate co-transporting polypeptide (NTCP). This interaction can be blocked by bulevirtide (BLV, formerly Myrcludex B), a preS1 derivative and approved drug for treating HDV infection. Here, to elucidate the basis of this inhibitory function, we determined a cryo-EM structure of BLV-bound human NTCP. BLV forms two domains, a plug lodged in the bile salt transport tunnel of NTCP and a string that covers the receptor’s extracellular surface. The N-terminally attached myristoyl group of BLV interacts with the lipid-exposed surface of NTCP. Our structure reveals how BLV inhibits bile salt transport, rationalizes NTCP mutations that decrease the risk of HBV/HDV infection, and provides a basis for understanding the host specificity of HBV/HDV. Our results provide opportunities for structure-guided development of inhibitors that target HBV/HDV docking to NTCP. 
650 4 |a Cryoelectron microscopy 
650 4 |a Membrane proteins 
700 1 |a Zakrzewicz, Dariusz  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Nosol, Kamil  |d 1993-  |e VerfasserIn  |0 (DE-588)1262000653  |0 (DE-627)1809417333  |4 aut 
700 1 |a Irobalieva, Rossitza N.  |e VerfasserIn  |4 aut 
700 1 |a Mukherjee, Somnath  |e VerfasserIn  |4 aut 
700 1 |a Bang-Sørensen, Rose  |e VerfasserIn  |4 aut 
700 1 |a Goldmann, Nora  |e VerfasserIn  |4 aut 
700 1 |a Kunz, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Rossi, Lorenzo  |e VerfasserIn  |4 aut 
700 1 |a Kossiakoff, Anthony A.  |e VerfasserIn  |4 aut 
700 1 |a Urban, Stephan  |e VerfasserIn  |0 (DE-588)1060263599  |0 (DE-627)79935399X  |0 (DE-576)174162049  |4 aut 
700 1 |a Glebe, Dieter  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Geyer, Joachim  |d 1973-  |e VerfasserIn  |0 (DE-588)143174274  |0 (DE-627)704411377  |0 (DE-576)335472656  |4 aut 
700 1 |8 3\p  |a Locher, Kaspar  |d 1969-  |e VerfasserIn  |0 (DE-588)1089342438  |0 (DE-627)85312468X  |0 (DE-576)459698982  |4 aut 
773 0 8 |i Enthalten in  |t Nature Communications  |d [London] : Springer Nature, 2010  |g 15(2024), Artikel-ID 2476, Seite 1-13  |h Online-Ressource  |w (DE-627)626457688  |w (DE-600)2553671-0  |w (DE-576)331555905  |x 2041-1723  |7 nnas  |a Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP 
773 1 8 |g volume:15  |g year:2024  |g elocationid:2476  |g pages:1-13  |g extent:13  |a Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP 
856 4 0 |u https://doi.org/10.1038/s41467-024-46706-w  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41467-024-46706-w  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 3\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20240709 
993 |a Article 
994 |a 2024 
998 |g 1060263599  |a Urban, Stephan  |m 1060263599:Urban, Stephan  |d 910000  |d 911700  |e 910000PU1060263599  |e 911700PU1060263599  |k 0/910000/  |k 1/910000/911700/  |p 11 
999 |a KXP-PPN1894695844  |e 4548315470 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"origin":[{"dateIssuedDisp":"[2010]-","publisher":"Springer Nature ; Nature Publishing Group UK","publisherPlace":"[London] ; [London]"}],"id":{"issn":["2041-1723"],"zdb":["2553671-0"],"eki":["626457688"]},"part":{"year":"2024","pages":"1-13","volume":"15","extent":"13","text":"15(2024), Artikel-ID 2476, Seite 1-13"},"recId":"626457688","disp":"Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCPNature Communications","title":[{"title":"Nature Communications","title_sort":"Nature Communications"}],"note":["Gesehen am 13.06.24"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"pubHistory":["2010-"],"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 09.07.2024"],"name":{"displayForm":["Hongtao Liu, Dariusz Zakrzewicz, Kamil Nosol, Rossitza N. Irobalieva, Somnath Mukherjee, Rose Bang-Sørensen, Nora Goldmann, Sebastian Kunz, Lorenzo Rossi, Anthony A. Kossiakoff, Stephan Urban, Dieter Glebe, Joachim Geyer, Kaspar P. Locher"]},"recId":"1894695844","id":{"doi":["10.1038/s41467-024-46706-w"],"eki":["1894695844"]},"origin":[{"dateIssuedDisp":"20 March 2024","dateIssuedKey":"2024"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"13 S."}],"language":["eng"],"person":[{"display":"Liu, Hongtao","given":"Hongtao","role":"aut","family":"Liu"},{"display":"Zakrzewicz, Dariusz","role":"aut","given":"Dariusz","family":"Zakrzewicz"},{"display":"Nosol, Kamil","family":"Nosol","given":"Kamil","role":"aut"},{"given":"Rossitza N.","role":"aut","family":"Irobalieva","display":"Irobalieva, Rossitza N."},{"display":"Mukherjee, Somnath","family":"Mukherjee","role":"aut","given":"Somnath"},{"family":"Bang-Sørensen","role":"aut","given":"Rose","display":"Bang-Sørensen, Rose"},{"display":"Goldmann, Nora","family":"Goldmann","role":"aut","given":"Nora"},{"family":"Kunz","role":"aut","given":"Sebastian","display":"Kunz, Sebastian"},{"role":"aut","given":"Lorenzo","family":"Rossi","display":"Rossi, Lorenzo"},{"family":"Kossiakoff","role":"aut","given":"Anthony A.","display":"Kossiakoff, Anthony A."},{"display":"Urban, Stephan","family":"Urban","role":"aut","given":"Stephan"},{"display":"Glebe, Dieter","given":"Dieter","role":"aut","family":"Glebe"},{"given":"Joachim","role":"aut","family":"Geyer","display":"Geyer, Joachim"},{"display":"Locher, Kaspar","given":"Kaspar","role":"aut","family":"Locher"}],"title":[{"title_sort":"Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP","title":"Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP"}]} 
SRT |a LIUHONGTAOSTRUCTUREO2020